A hybrid particle–hydrogel composite for oligonucleotide-mediated pulsatile protein release

The development of pulsatile protein delivery systems is challenging and can advance the treatment of various human diseases. Herein, we introduce a novel composite as the delivery system using nucleic aptamers to retain and release target proteins at will. The composite was composed of affinity particles embedded in a hydrogel network where the affinity particles were functionalized with the aptamers. Not only did the aptamers function as binding sites for proteins in the composite, but also as triggering sites for the pulsatile release of proteins. To demonstrate this idea, platelet-derived growth factor-BB, its aptamer, and agarose hydrogel were used as the model. Microscopy imaging revealed that the particles were well distributed in the composite. The measured storage and loss moduli did not differ significantly in comparison of the composite with the native agarose gel, indicating that the incorporated particles did not alter the mechanical properties of the material. The release experiment showed that the protein release rate in the aptamer-incorporated composite dramatically decreased in normal conditions as compared to the control composite due to the high binding affinity of the aptamers. After being triggered by complementary oligonucleotides, the system could release the bound proteins in a pulsatile manner at predetermined time points.

[1]  Kristi S Anseth,et al.  Controlling Affinity Binding with Peptide‐Functionalized Poly(ethylene glycol) Hydrogels , 2009, Advanced functional materials.

[2]  D. Pochan,et al.  Correlations between structure, material properties and bioproperties in self-assembled beta-hairpin peptide hydrogels. , 2008, Faraday discussions.

[3]  Aliasgar Shahiwala,et al.  Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[4]  S. Jayasena.  Aptamers: an emerging class of molecules that rival antibodies in diagnostics. , 1999, Clinical chemistry.

[5]  G. Prestwich,et al.  Effect of Gelatin on Heparin Regulation of Cytokine Release from Hyaluronan-Based Hydrogels , 2008, Drug delivery.

[6]  W. Saltzman,et al.  Controlled antibody release from a matrix of poly(ethylene‐co‐vinyl acetate) fractionated with a supercritical fluid , 1993 .

[7]  C. Frank,et al.  Effect of Particle Distribution on Morphological and Mechanical Properties of Filled Hydrogel Composites , 2008 .

[8]  Teruo Okano,et al.  Pulsatile drug release control using hydrogels. , 2002, Advanced drug delivery reviews.

[9]  Xinqiao Jia,et al.  Perlecan domain I-conjugated, hyaluronic acid-based hydrogel particles for enhanced chondrogenic differentiation via BMP-2 release. , 2009, Biomaterials.

[10]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[11]  P. Carmeliet.  Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.

[12]  Friedrich C Simmel,et al.  A DNA-based machine that can cyclically bind and release thrombin. , 2004, Angewandte Chemie.

[13]  Robert Langer,et al.  Multi-pulse drug delivery from a resorbable polymeric microchip device , 2003, Nature materials.

[14]  M. Fussenegger,et al.  Drug-sensing hydrogels for the inducible release of biopharmaceuticals. , 2008, Nature materials.

[15]  R. Buhmann,et al.  Aptamers—basic research, drug development, and clinical applications , 2005, Applied Microbiology and Biotechnology.

[16]  Wim E. Hennink,et al.  Self‐Exploding Beads Releasing Microcarriers , 2008 .

[17]  W. Murphy,et al.  Modulating growth factor release from hydrogels via a protein conformational change , 2009 .

[18]  Georg Brabant,et al.  Pulsatile patterns in hormone secretion , 1992, Trends in Endocrinology & Metabolism.

[19]  Green Nm,et al.  Avidin and streptavidin. , 1990 .

[20]  Yu Sun,et al.  Investigation of mechanical properties of soft hydrogel microcapsules in relation to protein delivery using a MEMS force sensor. , 2010, Journal of biomedical materials research. Part A.

[21]  Ke Peng,et al.  Cyclodextrin–dextran based in situ hydrogel formation: a carrier for hydrophobic drugs , 2010 .

[22]  E. Smela,et al.  Microfabricating conjugated polymer actuators. , 2000, Science.

[23]  Masao Kobayashi,et al.  Drug release from and mechanical properties of press-coated tablets with hydroxypropylmethylcellulose acetate succinate and plasticizers in the outer shell. , 2001, International journal of pharmaceutics.

[24]  Aaron D Baldwin,et al.  Production of heparin-functionalized hydrogels for the development of responsive and controlled growth factor delivery systems. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[25]  G. McConnell,et al.  Enzyme responsive polymer hydrogel beads. , 2005, Chemical communications.

[26]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[27]  Russell J. Stewart,et al.  Hybrid hydrogels assembled from synthetic polymers and coiled-coil protein domains , 1999, Nature.

[28]  Kenji Kaneko,et al.  Supramolecular hydrogel exhibiting four basic logic gate functions to fine-tune substance release. , 2009, Journal of the American Chemical Society.

[29]  R. Ulijn,et al.  Enzyme-responsive hydrogel particles for the controlled release of proteins: designing peptide actuators to match payload. , 2008, Soft matter.

[30]  D. Kohane,et al.  HYDROGELS IN DRUG DELIVERY: PROGRESS AND CHALLENGES , 2008 .

[31]  W. Tan,et al.  Engineering target-responsive hydrogels based on aptamer-target interactions. , 2008, Journal of the American Chemical Society.

[32]  K. Kiick.  Peptide- and protein-mediated assembly of heparinized hydrogels. , 2008, Soft matter.

[33]  Koen Raemdonck,et al.  Advanced nanogel engineering for drug delivery , 2009 .

[34]  B. Sullenger,et al.  RNA aptamers as reversible antagonists of coagulation factor IXa , 2002, Nature.

[35]  W. Saltzman,et al.  Organosilicate-polymer drug delivery systems: controlled release and enhanced mechanical properties. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[36]  A. Metters,et al.  Metal-chelating affinity hydrogels for sustained protein release. , 2007, Journal of biomedical materials research. Part A.

[37]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[38]  Jacek Wower,et al.  Nucleic acid therapeutic carriers with on-demand triggered release. , 2009, Bioconjugate chemistry.

[39]  David J. Mooney,et al.  Controlled growth factor release from synthetic extracellular matrices , 2000, Nature.

[40]  Y. Mi,et al.  Capture and release of protein by a reversible DNA-induced sol-gel transition system. , 2008, Angewandte Chemie.

[41]  Till Acker,et al.  Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions , 2001, Nature Medicine.

[42]  Jongseong Kim,et al.  Bioresponsive hydrogel microlenses. , 2005, Journal of the American Chemical Society.

[43]  C. Sen,et al.  Injectable, highly flexible, and thermosensitive hydrogels capable of delivering superoxide dismutase. , 2009, Biomacromolecules.

[44]  P. Carmeliet,et al.  Regulation of angiogenesis by tissue factor cytoplasmic domain signaling , 2004, Nature Medicine.

[45]  J. Hilborn,et al.  In situ cross-linkable high molecular weight hyaluronan-bisphosphonate conjugate for localized delivery and cell-specific targeting: a hydrogel linked prodrug approach. , 2009, Journal of the American Chemical Society.

[46]  Ralph Müller,et al.  Repair of bone defects using synthetic mimetics of collagenous extracellular matrices , 2003, Nature Biotechnology.

[47]  R. Langer,et al.  Light-induced shape-memory polymers , 2005, Nature.

[48]  Xinqiao Jia,et al.  Hybrid multicomponent hydrogels for tissue engineering. , 2009, Macromolecular bioscience.

[49]  J. Hubbell,et al.  Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[50]  R. Bodmeier,et al.  Pulsatile drug-delivery systems. , 2001, Critical reviews in therapeutic drug carrier systems.

[51]  M. Madou,et al.  Genetically engineered protein in hydrogels tailors stimuli-responsive characteristics , 2005, Nature Materials.

[52]  Nebojsa Janjic,et al.  Inhibitory DNA ligands to platelet-derived growth factor B-chain. , 1996, Biochemistry.

[53]  Xinqiao Jia,et al.  Structural Analysis and Mechanical Characterization of Hyaluronic Acid-Based Doubly Cross-Linked Networks. , 2009, Macromolecules.